“
North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027 by Treatment Type (Medication, Stem Cell Therapy, Others), ALS Type (Sporadic, Familial), Distribution Channel, and Country: Trend Outlook and Growth Opportunity
- 9036A
- Slides: 78
- June 2021
- Total Views:1370
- Region : Global
- Grace Market Data
- Market Research Report
About the Report
About the Report
North America amyotrophic lateral sclerosis treatment market is expected to grow by 5.0% annually in the forecast period and reach USD 270.6 million by 2027 owing to the increasing geriatric population worldwide coupled with growing prevalence rate of ALS, and the increase in R&D for new amyotrophic lateral sclerosis therapies.
Highlighted with 21 tables and 31 figures, this 78-page report North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 2020-2027 by Treatment Type (Medication, Stem Cell Therapy, Others), ALS Type (Sporadic, Familial), Distribution Channel, and Country: Trend Outlook and Growth Opportunity is based on a comprehensive research of the entire North America amyotrophic lateral sclerosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2027 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porter's Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America amyotrophic lateral sclerosis treatment market in every aspect of the classification from perspectives of Treatment Type, ALS Type, Distribution Channel, and Country.
Based on Treatment Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.
Medication
o Riluzole (Rilutek)
o Radicava (Edaravone)
o Tiglutik (Thickened Riluzole)
o Nuedexta
Stem Cell Therapy
Other Treatments
Based on ALS Type, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.
Sporadic ALS
Familial ALS
Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue (USD mn) for 2017-2027 included in each section.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Other Distribution Channels
Geographically, the following national/local markets are fully investigated:
U.S.
Canada
Mexico
For each key country, detailed analysis and data for annual revenue (USD mn) are available for 2017-2027. The breakdown of key national markets by Treatment Type, ALS Type, and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Key Players (this may not be a complete list and extra companies can be added upon request):
AB Science SA
Amylyx Pharmaceuticals Inc.
Biogen Inc.
Biohaven Pharmaceutical Holding Co., Ltd.
BrainStorm Cell Limited
Corestem, Inc.
F.Hoffmann-La Roche AG
Ionis Pharmaceuticals, Inc.
Mitsubishi Tanabe Pharma Corporation
Otsuka Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Products
Companies
Key Players (this may not be a complete list and extra companies can be added upon request):
AB Science SA
Amylyx Pharmaceuticals Inc.
Biogen Inc.
Biohaven Pharmaceutical Holding Co., Ltd.
BrainStorm Cell Limited
Corestem, Inc.
F.Hoffmann-La Roche AG
Ionis Pharmaceuticals, Inc.
Mitsubishi Tanabe Pharma Corporation
Otsuka Pharmaceutical Co., Ltd.
Sun Pharmaceutical Industries Ltd.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
Table of Contents
1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 11
1.2.6 Market Size/Share Estimation 12
1.2.7 Research Limitations 13
1.3 Executive Summary 14
2 Market Overview and Dynamics 16
2.1 Market Size and Forecast 16
2.1.1 Impact of COVID-19 on World Economy 17
2.1.2 Impact of COVID-19 on the Market 19
2.2 Major Growth Drivers 21
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porter's Fiver Forces Analysis 32
3 Segmentation of North America Market by Treatment Type 36
3.1 Market Overview by Treatment Type 36
3.2 Medication 38
3.3 Stem Cell Therapy 40
3.4 Other Treatments 41
4 Segmentation of North America Market by ALS Type 42
4.1 Market Overview by ALS Type 42
4.2 Sporadic ALS 44
4.3 Familial ALS 45
5 Segmentation of North America Market by Distribution Channel 46
5.1 Market Overview by Distribution Channel 46
5.2 Hospital Pharmacies 48
5.3 Retail Pharmacies 49
5.4 Online Pharmacies 50
5.5 Other Distribution Channels 51
6 North America Market 2020-2027 by Country 52
6.1 Overview of North America Market 52
6.2 U.S. 55
6.3 Canada 58
6.4 Mexico 60
7 Competitive Landscape 62
7.1 Overview of Key Vendors 62
7.2 New Product Launch, Partnership, Investment, and M&A 65
7.3 Company Profiles 66
AB Science SA 66
Amylyx Pharmaceuticals Inc. 68
Biogen Inc. 69
Biohaven Pharmaceutical Holding Co., Ltd. 70
BrainStorm Cell Limited 71
Corestem, Inc. 72
F.Hoffmann-La Roche AG 73
Ionis Pharmaceuticals, Inc. 74
Mitsubishi Tanabe Pharma Corporation 75
Otsuka Pharmaceutical Co., Ltd. 76
Sun Pharmaceutical Industries Ltd. 77
RELATED REPORTS 78
List of Figure
Figure 1. Research Method Flow Chart 9
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 12
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2020-2027 14
Figure 4. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, USD mn 16
Figure 5. Impact of COVID-19 on Business 19
Figure 6. Primary Drivers and Impact Factors of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 21
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 24
Figure 8. Primary Restraints and Impact Factors of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 25
Figure 9. Investment Opportunity Analysis 29
Figure 10. Porter's Fiver Forces Analysis of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 32
Figure 11. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2020-2027, % of Revenue 36
Figure 12. Contribution to North America 2021-2027 Cumulative Revenue by Treatment Type, Value (USD mn) and Share (%) 37
Figure 13. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication, 2017-2027, USD mn 38
Figure 14. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Stem Cell Therapy, 2017-2027, USD mn 40
Figure 15. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Treatments, 2017-2027, USD mn 41
Figure 16. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2020-2027, % of Revenue 42
Figure 17. Contribution to North America 2021-2027 Cumulative Revenue by ALS Type, Value (USD mn) and Share (%) 43
Figure 18. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Sporadic ALS, 2017-2027, USD mn 44
Figure 19. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Familial ALS, 2017-2027, USD mn 45
Figure 20. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2020-2027, % of Revenue 47
Figure 21. Contribution to North America 2021-2027 Cumulative Revenue by Distribution Channel, Value (USD mn) and Share (%) 47
Figure 22. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Hospital Pharmacies, 2017-2027, USD mn 48
Figure 23. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Retail Pharmacies, 2017-2027, USD mn 49
Figure 24. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Online Pharmacies, 2017-2027, USD mn 50
Figure 25. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Other Distribution Channels, 2017-2027, USD mn 51
Figure 26. Breakdown of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2020 and 2027, % of Revenue 53
Figure 27. Contribution to North America 2021-2027 Cumulative Revenue by Country, Value (USD mn) and Share (%) 54
Figure 28. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, USD mn 56
Figure 29. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market, 2017-2027, USD mn 58
Figure 30. Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Mexico, 2017-2027, USD mn 60
Figure 31. Growth Stage of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Industry over the Forecast Period 62
List of Table
Table 1. Snapshot of North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market in Balanced Perspective, 2020-2027 15
Table 2. Growth Rate of World GDP, 2020-2022 18
Table 3. Main Product Trends and Market Opportunities in North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market 28
Table 4. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, USD mn 36
Table 5. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Medication by Type, 2017-2027, USD mn 39
Table 6. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, USD mn 42
Table 7. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, USD mn 46
Table 8. North America Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Country, 2017-2027, USD mn 53
Table 9. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, USD mn 57
Table 10. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, USD mn 57
Table 11. U.S. Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, USD mn 57
Table 12. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, USD mn 59
Table 13. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, USD mn 59
Table 14. Canada Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, USD mn 59
Table 15. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Treatment Type, 2017-2027, USD mn 61
Table 16. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by ALS Type, 2017-2027, USD mn 61
Table 17. Mexico Amyotrophic Lateral Sclerosis (ALS) Treatment Market by Distribution Channel, 2017-2027, USD mn 61
Table 18. AB Science SA: Company Snapshot 66
Table 19. AB Science SA: Business Segmentation 66
Table 20. AB Science SA: Product Portfolio 67
Table 21. AB Science SA: Revenue, 2017-2019, USD mn 67
You can also purchase parts of this report. Do you want to check out a section wise price list?
Why Buy From US?
Refine Robust Result (RRR) Framework
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
Our Reach Is Unmatched
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
Shifting the Research Paradigm
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
More Insights-Better Decisions
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Transparency and Trust
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
Round the Clock Support
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.
Why Client Choose Us?
400000+
Reports in repository
150+
Consulting project a year
100+
Analysts
8000+
Client Queries in 2022
Trusted By 2500+ Brands
.png){kind=logo}
.svg.png)
What Our Clients Say About Us
“
We are very impressed with the speed and quality of the report which the team had put together. we engaged Ken Research to help us understand our customer segments, identify the market penetration and competition in Egypt Radiology Equipment Market. The coverage and the analysis of the data in the report was well aimed and accurate. It was a delight working with the team and we would not hesitate to use their services again when the opportunity arises."
“
I would like to thank you and the Ken Research team for all the great work that was done. Working with Ken Research was an amazing experience as the team was very dedicated, flexible, open to discussions and always ready to satisfy the customer needs. The task wasn’t an easy one but you completed it in a very professional way"
“
Inova Care is extremely pleased with the quality of work and professionalism of Ken Research based in Haryana, India. We had a complex research project with an extraordinarily tight timeline. Not only did Ken Research deliver the project on time, they were able to get market intelligence that truly contributed to the quality of our project in India. I would highly recommend Ken Research for any market research project in India."
“
We are happy to inform you that we have successfully filed yesterday with the SEC. The client is satisfied with the output provided by Ken Research as it comprehensively covers all the matters they wished to be included and at a tight timetable at that. On our end, we are grateful for the accommodations your team has given our team. We will definitely keep Ken Research in mind for our upcoming deals in the future that would require industry reports as well."
“
Kenresearch have been very helpful in assisting us gather industry knowledge and market knowledge on Indonesia. The level of detail and customisation that was done was also great given that not much data is available on public domain. Overall a great job"
